Mark Altmeyer: Founder and CEO of Arvelle Therapeutics

from BioBoss · host Mark Altmeyer

Mark Altmeyer, founder and CEO of Arvelle Therapeutics, speaks with BioBoss host John Simboli. Hear Mark’s thoughts about leadership and how Arvelle is working to bring new solutions to people living with epilepsy and CNS disorders.

Episode metadata supplied by the publisher feed · Published Oct 17, 2020

Embed this episode

Attribution link and audio player

Ready to play

Mark Altmeyer: Founder and CEO of Arvelle Therapeutics

0:00 33:59

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioBoss?

This episode is 33 minutes long.

When was this BioBoss episode published?

This episode was published on October 17, 2020.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this BioBoss episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!